BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
about
Interventions for lowering plasma homocysteine levels in kidney transplant recipientsPretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney TransplantationCardiovascular morbidity and mortality after kidney transplantation.The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.Long-Term Changes in Blood Pressure After Pediatric Kidney Transplantation.
P2860
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@ast
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@en
type
label
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@ast
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@en
prefLabel
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@ast
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@en
P2093
P2860
P356
P1476
BP, cardiovascular disease, an ...... tion in Transplantation trial.
@en
P2093
Anastasia Ivanova
Andrew Bostom
Andrew S Levey
Bertram L Kasiske
Daniel E Weiner
John W Kusek
Lawrence Hunsicker
Matthew R Weir
Myra A Carpenter
P2860
P304
P356
10.1681/ASN.2013040435
P577
2014-03-13T00:00:00Z